### Analysis of rs794726721 in Cis-Acting Elements

#### 1. Variant Identification
- **rs Number**: [rs794726721](https://identifiers.org/dbsnp/rs794726721)
- **Gene Name**: SCN1A (Sodium Voltage-Gated Channel Alpha Subunit 1) and SCN1A-AS1 (SCN1A Antisense RNA 1)
- **HGVS Notations**:
  - For SCN1A: Multiple transcripts are affected, including:
    - `NM_006920.6:c.2695C>T` (p.Gln899Ter, nonsense mutation)
    - `NM_006920.6:c.2695C>A` (p.Gln899Lys, missense mutation)
  - For SCN1A-AS1: Variants in non-coding regions, such as:
    - `ENST00000595268.3:n.115+1864G>A`
    - `ENST00000595268.3:n.115+1864G>T`
- **TogoVar Link**: [TogoVar rs794726721](https://togovar.org/variant/rs794726721)

#### 2. Effects on Cis-Acting Elements
The variant rs794726721 is located in the **SCN1A-AS1** gene, which is an antisense RNA gene overlapping the SCN1A locus. Variants in SCN1A-AS1 may affect **cis-regulatory elements** such as enhancers, silencers, or other non-coding regulatory regions. Specifically:
- **SCN1A-AS1** is known to regulate the expression of SCN1A, and changes in this region could disrupt the normal transcriptional regulation of SCN1A.
- The variant is annotated with consequences such as:
  - **SO_0001627**: Non-coding transcript variant
  - **SO_0001619**: Intron variant
  These suggest that the variant may alter splicing or regulatory functions in the non-coding RNA.

#### 3. Disease Associations
- The variant is associated with **Severe Myoclonic Epilepsy in Infancy (SMEI)**, also known as Dravet syndrome. This condition is linked to mutations in SCN1A, and disruptions in cis-regulatory elements could exacerbate the disease phenotype by altering SCN1A expression.

#### 4. Predictive Models
- No specific predictive models (e.g., SIFT, PolyPhen) are available for the non-coding effects of this variant. However, the missense and nonsense mutations in SCN1A caused by rs794726721 are predicted to have **deleterious effects**.

#### 5. Literature Evidence
- No direct publications were retrieved from the TogoVar API for the cis-regulatory effects of rs794726721. However, SCN1A-AS1's role in regulating SCN1A expression is well-documented in the context of epilepsy.

#### 6. Population Frequency
- The allele frequency for the G>A variant is **4.25e-05** in the NCBI database, indicating it is rare. No frequency data is available for the G>T variant.

---

### Summary in Japanese
#### rs794726721のシス作用エレメントへの影響

1. **変異の特定**
   - **rs番号**: [rs794726721](https://identifiers.org/dbsnp/rs794726721)
   - **遺伝子名**: SCN1AおよびSCN1A-AS1
   - **HGVS表記**:
     - SCN1A: `NM_006920.6:c.2695C>T` (ナンセンス変異) および `NM_006920.6:c.2695C>A` (ミスセンス変異)
     - SCN1A-AS1: 非コード領域の変異例として `ENST00000595268.3:n.115+1864G>A` など
   - **TogoVarリンク**: [TogoVar rs794726721](https://togovar.org/variant/rs794726721)

2. **シス作用エレメントへの影響**
   - **SCN1A-AS1**はSCN1A遺伝子の発現を調節するアンチセンスRNAであり、この領域の変異はSCN1Aの転写調節を妨げる可能性があります。
   - この変異は以下の影響を持つ可能性があります：
     - **SO_0001627**: 非コード転写産物変異
     - **SO_0001619**: イントロン変異
   - これにより、スプライシングや調節機能が変化する可能性があります。

3. **疾患との関連**
   - この変異は**乳児重症ミオクロニーてんかん（SMEI、Dravet症候群）**と関連しています。SCN1Aの発現調節の破壊が疾患表現型を悪化させる可能性があります。

4. **予測モデル**
   - 非コード領域の影響に関する具体的な予測モデル（SIFT、PolyPhenなど）はありませんが、SCN1Aのミスセンスおよびナンセンス変異は**有害**と予測されています。

5. **文献証拠**
   - SCN1A-AS1のSCN1A発現調節における役割はてんかんの文脈で広く知られていますが、rs794726721のシス調節効果に関する直接的な文献は見つかりませんでした。

6. **集団頻度**
   - G>A変異のアレル頻度は**4.25e-05**と非常に稀です。G>T変異の頻度データはありません。

---

For further exploration, you can visit the [TogoVar page for rs794726721](https://togovar.org/variant/rs794726721).